DR. MOHAMED M ZAKKAR M.D.
Prescription History 1285646828
Internal Medicine - Pulmonary Disease in Chicago Ridge, IL
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. MOHAMED M ZAKKAR M.D., an active Pulmonary Disease specialist practicing in Chicago Ridge, IL. Our medical registry currently tracks 8 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 399 documented patient claims. Among these therapy options, the most frequently utilized medication is Trelegy Ellipta, which accounts for 91 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other IL PrescribersVs. IL Avg |
|---|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 91 | $766.44▼ below IL avg | ▲ More than typical |
About Trelegy Ellipta: This product is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by asthma and ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾ Controlling symptoms of breathing problems helps you stay active. This inhaler contains 3 medications: fluticasone, umeclidinium, and vilanterol. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing swelling of the airways in the lungs to make breathing easier. Umeclidinium belongs to a class of drugs known as anticholinergics and vilanterol is a LABA medication. Both drugs work by relaxing the muscles around the airways so that they open up and you can breathe more easily. Both drugs are also known as bronchodilators. When used alone, long-acting beta agonists (such as vilanterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination products containing both an inhaled corticosteroid and long-acting beta agonist, such as this product, do not increase the risk of serious asthma-related breathing problems. For asthma treatment, this product should be used when breathing problems are not well controlled with two asthma-control medications (such as inhaled corticosteroid and long-acting beta agonist) or if your symptoms need combination treatment. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden shortness of breath. If sudden breathing problems occur, use your quick-relief inhaler as prescribed. In 2023, this provider wrote 91 Medicare prescriptions for Trelegy Ellipta, about 1.8 times the volume of the typical Illinois prescriber of this medication (51). Medicare paid an average of $766.44 per fill, versus $870.99 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IL average for this medication. 101 30-Day Fills standardized to 30-day supplies 3,030 Days of Medication total across all patients in 2023 | |||
| Prednisone | 71 | $2.80▼ below IL avg | ▲ More than typical |
About Prednisone: Prednisone is used to treat conditions such as arthritis, blood disorders, breathing problems, severe allergies, skin diseases, cancer, eye problems, and immune system disorders. Show more ▾ Prednisone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. In 2023, this provider wrote 71 Medicare prescriptions for Prednisone, about 1.6 times the volume of the typical Illinois prescriber of this medication (45). Medicare paid an average of $2.80 per fill, versus $6.07 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IL average for this medication. 71 30-Day Fills standardized to 30-day supplies 633 Days of Medication total across all patients in 2023 | |||
| SymbicortBudesonide/Formoterol Fumarate | 64 | $653.81 | ▲ More than typical |
About Symbicort: This product is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma or ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾ It contains 2 medications: budesonide and formoterol. Budesonide belongs to a class of drugs known as corticosteroids. It works by reducing the irritation and swelling of the airways. Formoterol belongs to the class of drugs known as long-acting beta agonists. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. When used alone, long-acting beta agonists (such as formoterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination inhaled corticosteroid and long-acting beta agonists, such as this product, do not increase the risk of serious asthma-related breathing problems. Before using this medication, it is important to learn how to use it properly. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. See also How to Use section. A pharmaceutical preparation of budesonide and formoterol fumarate that is used as an ANTI-ASTHMATIC AGENT and for the treatment of CHRONIC OBSTRUCTIVE PULMONARY DISEASE. In 2023, this provider wrote 64 Medicare prescriptions for Symbicort, about 1.9 times the volume of the typical Illinois prescriber of this medication (34). Medicare paid an average of $653.81 per fill, versus $541.78 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 101 30-Day Fills standardized to 30-day supplies 3,030 Days of Medication total across all patients in 2023 | |||
| Montelukast Sodium | 51 | $10.81▼ below IL avg | ≈ Typical |
About Montelukast Sodium: Montelukast is used to control and prevent symptoms caused by asthma (such as wheezing and shortness of breath). Show more ▾ It is also used before exercise to prevent breathing problems during exercise (bronchospasm). This medication can help decrease the number of times you need to use your quick relief inhaler. Montelukast is also used to relieve symptoms of hay fever and allergic rhinitis (such as sneezing, stuffy/runny/itchy nose). Since there are other allergy medications that may be safer (see also Warning section), this medication should be used for this condition only when you cannot take other allergy medications or they do not work well. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks or breathing problems. If an asthma attack or sudden shortness of breath occurs, use your quick-relief inhaler as prescribed. This drug works by blocking certain natural substances (leukotrienes) that may cause or worsen asthma and allergies. It helps make breathing easier by reducing swelling (inflammation) in the airways. In 2023, this provider wrote 51 Medicare prescriptions for Montelukast Sodium, about the same volume as the typical Illinois prescriber of this medication (54). Medicare paid an average of $10.81 per fill, versus $17.93 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IL average for this medication. 79 30-Day Fills standardized to 30-day supplies 2,370 Days of Medication total across all patients in 2023 | |||
| Albuterol Sulfate HfaAlbuterol Sulfate | 47 | $47.89▼ below IL avg | ≈ Typical |
About Albuterol Sulfate Hfa: Albuterol (also known as salbutamol) is used to treat wheezing and shortness of breath caused by breathing problems such as asthma. Show more ▾ It is a quick-relief medication. Albuterol belongs to a class of drugs known as bronchodilators. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol. In 2023, this provider wrote 47 Medicare prescriptions for Albuterol Sulfate Hfa, about the same volume as the typical Illinois prescriber of this medication (51). Medicare paid an average of $47.89 per fill, versus $50.28 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IL average for this medication. 66.2 30-Day Fills standardized to 30-day supplies 1,685 Days of Medication total across all patients in 2023 | |||
| Breo ElliptaFluticasone/Vilanterol | 35 | $585.20 | ≈ Typical |
About Breo Ellipta: This medication is used to prevent and decrease symptoms (wheezing and trouble breathing) caused by asthma and ongoing lung disease (chronic obstructive pulmonary disease-COPD, including chronic bronchitis and emphysema). Show more ▾ This inhaler contains 2 medications: fluticasone and vilanterol. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing the swelling of the airways in the lungs to make breathing easier. Vilanterol belongs to a class of drugs known as long-acting beta agonists. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. When used alone, long-acting beta agonists (like vilanterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination inhaled corticosteroid and long-acting beta agonists, such as this product, do not increase the risk of serious asthma-related breathing problems. For asthma treatment, this product should be used when breathing problems are not well controlled with one asthma-control medication (such as inhaled corticosteroid) or if your symptoms need combination treatment. Before using this medication, it is important to learn how to use it properly. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. In 2023, this provider wrote 35 Medicare prescriptions for Breo Ellipta, about the same volume as the typical Illinois prescriber of this medication (34). Medicare paid an average of $585.20 per fill, versus $538.74 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 49 30-Day Fills standardized to 30-day supplies 1,470 Days of Medication total across all patients in 2023 | |||
| Spiriva RespimatTiotropium Bromide | 21 | $1,006.17 | ▼ Less than typical |
About Spiriva Respimat: Tiotropium is used to control and prevent symptoms (such as wheezing, shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD which includes bronchitis and emphysema). Show more ▾ It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Tiotropium belongs to a class of drugs known as anticholinergics. Controlling symptoms of breathing problems can decrease time lost from work or school. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden breathing problems. If wheezing or sudden shortness of breath occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. A scopolamine derivative and CHOLINERGIC ANTAGONIST that functions as a BRONCHODILATOR AGENT. It is used in the treatment of CHRONIC OBSTRUCTIVE PULMONARY DISEASE. In 2023, this provider wrote 21 Medicare prescriptions for Spiriva Respimat, about 70% of the volume of the typical Illinois prescriber of this medication (30). Medicare paid an average of $1,006.17 per fill, versus $679.35 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 39.5 30-Day Fills standardized to 30-day supplies 1,185 Days of Medication total across all patients in 2023 | |||
| OfevNintedanib Esylate | 19 | $12,530.07 | ▼ Less than typical |
About Ofev: This medication is used to treat certain types of lung disease (idiopathic pulmonary fibrosis- IPF, interstitial lung disease). Show more ▾ Both types of lung disease scar and stiffen your lungs, making it hard to breathe. Nintedanib may help slow down the worsening of your lung disease. In 2023, this provider wrote 19 Medicare prescriptions for Ofev, about half the volume of the typical Illinois prescriber of this medication (34). Medicare paid an average of $12,530.07 per fill, versus $12,405.43 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 19 30-Day Fills standardized to 30-day supplies 570 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for DR. MOHAMED M ZAKKAR M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Pulmonary Disease prescribing approach at this Chicago Ridge, IL practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among IL prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
